Warning: This security is no longer trading.
Gilead Sciences Completes Acquisition of Kite Pharma, Inc.
Kite Pharma, Inc. (KITE): Price and Financial Metrics
KITE Price/Volume Stats
| Current price | $179.99 | 52-week high | $179.99 |
| Prev. close | $179.79 | 52-week low | $39.82 |
| Day low | $179.99 | Volume | 100 |
| Day high | $179.99 | Avg. volume | 1,652,408 |
| 50-day MA | $151.18 | Dividend yield | N/A |
| 200-day MA | $92.97 | Market Cap | 10.33B |
KITE Stock Price Chart Interactive Chart >
Kite Pharma, Inc. (KITE) Company Bio
Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T cell therapy designed to restore the immune system's ability to recognize and eradicate tumors. The company was founded in 2009 and is based in Santa Monica, California.
KITE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...